Study unravels a cause of resistance to novel drug in patients with acute leukemia



Study unravels a cause of resistance to novel drug in patients with acute leukemia

A new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells to reveal one of their schemes for resisting the drug, investigators report in a new pair of studies.

Materials provided by Dana-Farber Cancer Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

18th March 2023

New combination of drugs works together to reduce lung tumors in mice

Read more
17th March 2023

Study offers a potential strategy to improve T cell therapy in solid tumors

Read more
17th March 2023

Researchers chart a course for understanding, preventing, and treating young-onset colorectal cancer

Read more